Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Cohen Marc A, Director. Insider active across 1 company, notably C4 Therapeutics, Inc.. Aggregated, 4 filings have been logged. Activity tracked since 14 June 2021. The latest transaction was disclosed on 4 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Marc A. Cohen is a Board Member at C4 Therapeutics, Inc. He plays a key role in the governance and strategy of the company. Cohen brings expertise in the biopharmaceutical sector, which is essential for the development of C4 Therapeutics.